IP Strategies to Combat Distribution of Counterfeit Drugs

Counterfeit products are no longer restricted to Gucci purses and Rolex watches. The pharmaceutical sector has seen an alarming rise in the number of counterfeit products entering traditional distribution and supply chains. As a result, consumers unknowingly purchase counterfeit pharmaceuticals from their local pharmacy and receive little or no therapeutic benefit, or worse, die as a result of ingesting the counterfeited product.

Read the complete article by clicking on the link below.